Work as Director Clinical Portfolio Management Consultant at CDSA | Salary Upto Rs.3,00,000/-pm

Clinical Development Services Agency (CDSA) is an extramural unit of Translational Health Science and Technology Institute (THSTI) and has been established as a not-for-profit society to provide cost affective, high quality preclinical and clinical product development support services to meet the country’s growing healthcare needs. It will tend enterprises; particularly SMEs involved in new technology innovation and facilitate translation of scientific know-how into viable products.

Post : Director Clinical Portfolio Management (CPM)/ Consultant

Job for Professor, Associate Professor, Assistant Professor at Sri Ram Nallamani Yadava Educational Institutions

Sri Ram Nallamani Yadava College of Arts and Science, situated on the verdurous, fertile and magnificent foothills of the Western Ghat near Tenkasi, is run by the management of Sri Ram Nallamani Yadava Educational Society. The college stands as apillar of support to the rural youth who are badly in need of facilities for the prosecution of higher studies. The college is a coeducational institution approved by the Government of Tamil Nadu and affiliated to Manonmaniam Sundaranar University.

Require Assistant Manager Production, QA Officer at Medley Pharmaceuticals Ltd

Medley Pharmaceuticals Ltd is a progressive WHOGMP certified; besides approved by several other countries and one of the fastest growing company amongst the top 35 pharmaceutical companies In the country as per IMS.

Job for Life Sciences graduates at DXC Technology

DXC Technology is a technology company headquartered in Tysons Corner, Virginia. DXC provides information technology and consulting services to businesses and governments.

Post : Professional 1 Regulatory Publishing

Production, Packing, QC Jobs at Otsuka Pharmaceuticals India Pvt. Ltd | M.Pharm, B.Pharm, M.Sc

Otsuka Pharmaceutical India Private Limited (OPI) is a Joint Venture between Otsuka Pharmaceutical Factory, Inc., Japan and Mitsui & Co. Ltd., Japan, India, for Infusion Business in India and Emerging Markets.

Work as Program Management Manager at Piramal Critical Care | M.Pharm, B.Pharm, M.Sc

Piramal Healthcare Limited A major force in the pharmaceuticals and healthcare segment, Piramal Healthcare Limited, incorporating Healthcare Solutions & Pharma Solutions, has an unequivocal vision – to become the most admired pharmaceutical company, with leadership in market share and profits.

Post : Manager - Program Management

Cipla Limited announced the launch of remdesivir under its brand name CIPREMI. The U.S. FDA issued an Emergency Use Authorization (EUA) to Gilead Sciences Inc. for emergency use of remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients. It is the only U.S. FDA approved Emergency Use Authorisation (EUA) treatment for adult and paediatric patients hospitalized with suspected or laboratory confirmed COVID-19 infection. In May, Gilead Sciences Inc. extended a voluntary non-exclusive license to Cipla to manufacture and market Cipla’s generic version of remedisvir called CIPREMI.

A novel formulation of the prostate cancer drug abiraterone acetate - currently marketed as Zytiga - will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University of South Australia show the new formulation improves the drug's effectiveness by 40 per cent.

Caption : A novel formulation of the prostate cancer drug abiraterone acetate - currently marketed as Zytiga - will dramatically improve the quality of life for people suffering from prostate cancer. Credit : Hayley Schultz/UniSA

Hetero, one of India’s leading generic pharmaceutical companies, announced today that it has received the manufacturing and marketing approval for the investigational antiviral medicine ‘Remdesivir’ from the Drug Controller General of India (DCGI) for the treatment of Covid-19. Hetero’s generic version of Remdesivir will be marketed under the brand name ‘COVIFOR’ in India.